Mark S. Forman
Chief Medical Officer, Passage BIO, Inc.
Companies
- Ventyx Biosciences, Inc.Chief Medical Officer Aug 13, 2024 to now1
- Passage BIO, Inc.Chief Medical Officer Apr 8, 2022 to Mar 19, 20242
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Passage BIO, Inc. PASG48,631 shares3$175.1K at $3.60Feb 13, 2024
- Ventyx Biosciences, Inc.0 shares4Mar 4, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Mar 4, 2026Returned to company 6,000 shares of Ventyx Biosciences, Inc.4
- Nov 17, 2025Granted 3,000 shares at $1.03 of Ventyx Biosciences, Inc.5
- May 15, 2025Granted 3,000 shares at $1.03 of Ventyx Biosciences, Inc.6
- Feb 13, 2024Sold 1,638 shares at $0.97 of Passage BIO, Inc.3
- Feb 10, 2024Exercised options 5,000 shares of Passage BIO, Inc.3
- Jan 2, 2024Sold 15,813 shares at $0.91 of Passage BIO, Inc.7
- Dec 31, 2023Exercised options 50,000 shares of Passage BIO, Inc.7
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5SEC EDGARForm 4 filed Nov 19, 2025
- 6SEC EDGARForm 4 filed May 16, 2025
- 7SEC EDGARForm 4 filed Jan 3, 2024